Study Set: PCOL CHAPTER 8

a nonselective antagonist, has been

approved and is comparable in efficacy and side

effects to oxybutynin.

Trospium,

Click To Flip the Card

Comments:

PCOL CHAPTER 8

navigate_before navigate_next